Is Shilajit Safe in the UK? (2026)
Side effects, heavy metals, medical contraindications, and a buyer-protection framework — built on regulatory and peer-reviewed sources only.
Is Shilajit Safe in the UK? Side Effects, Heavy Metals & Medical Risk Analysis (2026 Guide)
- Short answerPure, purified, and independently lab-tested shilajit resin is considered safe for most healthy adults at 300–500 mg/day.
- Primary riskUntested products may contain lead, arsenic, mercury, or cadmium above WHO safety thresholds.
- UK regulatory statusClassified as a food supplement under FSA jurisdiction; no NHS endorsement; MHRA governs medicinal claims.
- Key safety signalA 2025 peer-reviewed study detected elevated thallium in multiple processed shilajit supplements from commercial markets.
- Safe buyer actionRequire a batch-specific COA from an ISO 17025-accredited lab before purchasing any UK product.
Why Shilajit Safety Is Not a Simple Yes or No Answer
Shilajit safety depends on product quality, not the substance category alone. The same compound that has documented therapeutic mechanisms in peer-reviewed literature also carries documented contamination risks in poorly sourced and untested products.
The UK supplement market is large and largely self-regulated. The Food Standards Agency (FSA) does not conduct mandatory pre-market testing of food supplements before they reach consumers. This market-entry gap means any manufacturer can sell a product labelled “pure Himalayan shilajit” without independent verification of that claim.
The scientific literature on shilajit safety distinguishes clearly between two categories: purified shilajit (processed to remove contaminants) and raw or unpurified shilajit (which may retain heavy metals, mycotoxins, and microbial contaminants at harmful levels). Most safety concerns in the literature pertain to the second category.
This guide applies a Tier 1–3 claim hierarchy throughout. Regulatory sources (NHS, FSA, MHRA, WHO) and peer-reviewed studies (PubMed) are treated as authoritative. Market observations and brand claims are noted as unverified unless supported by published documentation.
What Is Shilajit? A Regulatory and Scientific Definition
Shilajit is a blackish-brown mineral exudate formed over centuries by the compression and microbial decomposition of plant matter in high-altitude rock strata, primarily in the Himalayas, Altai, and Caucasus mountain ranges. It is classified as a food supplement in the United Kingdom under the Food Supplements (England) Regulations 2003.
The primary bioactive constituents of shilajit are fulvic acid, humic acid, and a complex matrix of 85+ trace minerals. Fulvic acid is responsible for the majority of its documented biological activity, including mineral transport, antioxidant function, and cellular membrane permeability enhancement. [PubMed: Bhavsar et al., 2012]
The fulvic acid content of commercial shilajit varies significantly by source altitude, geological origin, and purification method. Himalayan-sourced resin from altitudes above 16,000 feet consistently yields higher fulvic acid concentrations than lower-altitude or non-Himalayan sources. The documented benefits of shilajit are directly linked to verified fulvic acid content, not to brand marketing claims.
For UK regulatory purposes, shilajit is not classified as a medicine and may not legally be marketed with disease-treatment claims. Any medicinal claim triggers MHRA oversight under the Human Medicines Regulations 2012.
UK Regulatory Framework: FSA, NHS, and MHRA Positions on Shilajit
Understanding the regulatory environment is the first step to understanding why shilajit safety varies by product, not by category.
Food Standards Agency (FSA)
The FSA regulates shilajit as a food supplement under the Food Supplements (England) Regulations 2003. Under this framework, supplements may be sold without pre-market approval or efficacy testing. [FSA: Food Supplements Guidance]
Manufacturers bear legal responsibility for ensuring their products are safe before placing them on market. The FSA does not test individual products before sale. Post-market enforcement action is possible if a product is found to be unsafe.
Shilajit does not appear on the FSA’s Novel Foods authorisation list as a previously approved ingredient, and it is not currently subject to specific positive-list mineral or vitamin restrictions under the Food Supplements Directive. Its sale is therefore legal in the UK provided it meets general food safety law under the Food Safety Act 1990.
NHS Position
The NHS does not recognise shilajit as a clinically recommended supplement. The NHS supplements guidance explicitly states that most people do not need supplements if they eat a balanced diet, and cautions against self-prescribing for specific health conditions without medical advice. [NHS: Vitamins and Minerals]
The NHS does not endorse, contraindicate, or publish specific guidance on shilajit. This means the substance exists in a regulatory information gap for UK consumers relying solely on NHS sources.
MHRA Role
The Medicines and Healthcare products Regulatory Agency (MHRA) governs any claim that a shilajit product can treat, prevent, or cure a medical condition. Such claims would reclassify the product as a medicine, requiring a marketing authorisation. [MHRA: Traditional Herbal Medicines]
Shilajit does not currently hold a Traditional Herbal Registration (THR) in the UK. Products sold as supplements making implied health claims are legal, but explicit medicinal claims are not.
No UK regulatory body tests shilajit products before they reach shelves. The FSA, NHS, and MHRA each have jurisdiction over specific aspects of sale and labelling but none conducts routine pre-market product safety testing. The practical result is that product safety depends entirely on the manufacturer’s own testing protocols and transparency.
Shilajit and Heavy Metals: Lead, Mercury, Arsenic & Cadmium Risk Analysis
Heavy metal contamination is the primary documented safety risk associated with shilajit. This risk is not theoretical — it has been confirmed in peer-reviewed literature and in market surveillance reports across multiple countries.
Why Shilajit Naturally Accumulates Heavy Metals
Shilajit forms in geological strata that contain naturally occurring heavy metals. The same mineral-rich environment that produces the fulvic acid matrix also concentrates metals including lead (Pb), arsenic (As), mercury (Hg), and cadmium (Cd). [PubMed: Ghosal et al., 2003]
Lower-altitude sources and sources near agricultural or industrial areas carry higher contamination risk due to environmental runoff. Himalayan sources above 18,000 feet are significantly more isolated from industrial contamination but are not inherently free of naturally occurring metals without purification.
Purification processes — including water-based extraction, filtration, and temperature-controlled processing — are designed to reduce heavy metal concentrations to below regulatory safety thresholds. The effectiveness of purification is product-specific and must be verified by laboratory testing, not assumed from altitude or origin claims alone.
WHO and USP Heavy Metal Safety Thresholds
| Heavy Metal | WHO Guideline (µg/day) | USP <232> Oral Limit (µg/day) | Health Risk at Excess Exposure | Detection in Shilajit Literature |
|---|---|---|---|---|
| Lead (Pb) | ≤10 µg/day | 5 µg/day | Neurotoxicity, nephrotoxicity, developmental harm in children | Confirmed in multiple untested commercial products [PubMed] |
| Arsenic (As) | ≤10 µg/day | 15 µg/day | Carcinogen (Group 1, IARC), peripheral neuropathy, skin lesions | Elevated in low-altitude and river-proximate sources |
| Mercury (Hg) | ≤2 µg/day (inorganic) | 3 µg/day | Renal toxicity, CNS damage, immunotoxicity | Lower frequency; risk increases in non-Himalayan sources |
| Cadmium (Cd) | ≤25 µg/week (EFSA) | 4.1 µg/day | Kidney damage (proximal tubule), bone demineralisation | Present in soil-contaminated lower-altitude sources |
| Thallium (Tl) | No established tolerable intake | No oral supplement limit set | Severe neurological toxicity; no safe threshold established | Elevated levels found in processed shilajit supplements (2025 study) [PubMed, 2025] |
| Sources: WHO Guidelines for Drinking-Water Quality; USP <232> Elemental Impurities — Limits; EFSA dietary exposure assessments. Thallium data: 2025 peer-reviewed analysis of commercial shilajit supplements. | ||||
What the 2025 Research Found
A 2025 peer-reviewed study analysed the elemental composition of commercially available shilajit supplements across multiple international markets. The study identified elevated thallium concentrations in several processed products — a finding of concern because thallium has no established safe oral intake level and is acutely toxic at low doses. [PubMed, 2025 — Shilajit elemental analysis]
The study also reported significant variation in lead and arsenic concentrations across brands, with some products exceeding WHO daily tolerable intake limits at recommended serving sizes.
These findings reinforce the consensus position: heavy metal risk in shilajit is product-specific, not categorical. A verified, properly purified product from a high-altitude source with published third-party lab results presents a fundamentally different risk profile than an unverified product.
A Certificate of Analysis stating “heavy metals tested” without published numerical results is not sufficient verification. The COA must show actual measured values (in µg/g or ppm) for each metal, compared against the applicable regulatory threshold. Absence of numbers on a COA is a red flag equivalent to no testing at all.
Nature Elixirs publishes full batch-specific heavy metal panel results on its website, including numerical values for lead, arsenic, mercury, and cadmium. These can be reviewed independently at the lab reports page before any purchase decision.
Shilajit Side Effects: Clinically Documented and Reported Adverse Effects
Side effects from shilajit can be divided into two categories: those attributable to the purified compound’s own biological activity, and those attributable to contaminants in poorly purified products. These must not be conflated.
Side Effects Attributable to Shilajit’s Biological Activity
| Side Effect | Mechanism | Population at Risk | Evidence Level |
|---|---|---|---|
| Elevated uric acid | Shilajit contains purine-related compounds; high doses may increase serum urate. [PubMed] | Individuals with gout or hyperuricaemia | Tier 2 — peer-reviewed |
| Increased iron absorption | Fulvic acid enhances mineral bioavailability, including iron uptake. | Individuals with haemochromatosis or elevated serum ferritin | Tier 2 — mechanism confirmed |
| Lowered blood pressure | Possible vasodilatory and diuretic effect at higher doses. | Individuals on antihypertensive medication | Tier 3 — case-level observations |
| Mild digestive upset | High single-dose mineral load may cause transient nausea or loose stools. | Individuals with sensitive GI tracts; dose-dependent | Tier 3 — user-reported |
| Hormonal changes | Testosterone-modulating effects observed in clinical trials may affect individuals on hormonal therapy. [PubMed: Pandit et al., 2016] | Individuals on testosterone replacement or anti-androgen therapy | Tier 2 — RCT data |
| Allergic reaction | Rare. Possible hypersensitivity to constituent minerals or humic compounds. | General population; incidence low | Tier 3 — case reports only |
| Side effects listed apply to purified shilajit at recommended doses. Contaminant-related effects (heavy metal toxicity) are covered in the section above. | |||
Contraindications: Who Should Not Take Shilajit
- Pregnant or breastfeeding women: No safety data exists for this population. Avoid on precautionary grounds.
- Children and adolescents under 18: No paediatric dosing studies exist. Not recommended.
- Haemochromatosis: Fulvic acid’s iron-enhancing effect is contraindicated in iron-overload conditions.
- Active kidney disease: Mineral load and potential contaminants increase nephrotoxic risk.
- Active liver disease: Liver is primary detoxification organ; additional mineral load is inadvisable.
- Autoimmune conditions: Immunomodulatory effects may be unpredictable in conditions such as lupus, multiple sclerosis, or rheumatoid arthritis.
- Surgery: Discontinue at least 2 weeks prior to elective surgery due to possible effects on blood pressure and iron metabolism.
Individuals with any pre-existing medical condition or those taking prescription medications should consult a qualified healthcare professional before taking shilajit. This is not a precautionary marketing disclaimer — it reflects a genuine absence of drug-interaction data in the peer-reviewed literature for most medication classes.
Shilajit Drug Interactions: Known and Theoretical Risks
Shilajit’s mineral-transport and bioavailability-enhancing properties mean it can affect the absorption, metabolism, or excretion of certain pharmaceutical compounds. Interaction data is limited but sufficient to warrant caution in the following categories.
| Drug / Drug Class | Type of Interaction | Clinical Relevance |
|---|---|---|
| Antihypertensives (e.g. amlodipine, lisinopril, beta-blockers) |
Possible additive blood pressure lowering effect | Monitor blood pressure; risk of hypotension at high shilajit doses |
| Anticoagulants / Blood thinners (e.g. warfarin, rivaroxaban) |
Theoretical potentiation; mechanism unclear | Avoid concurrent use without haematology advice; INR monitoring advised for warfarin users |
| Iron supplements / Iron-containing drugs | Fulvic acid increases iron absorption significantly | Risk of iron overload; do not combine with therapeutic iron supplementation unless monitored |
| Diabetes medications (e.g. metformin, insulin) |
Shilajit may have mild blood glucose modulating effects [PubMed] | Monitor blood glucose closely; risk of additive hypoglycaemia |
| Testosterone / Hormonal therapy | Shilajit demonstrated testosterone-elevating effects in clinical trials | May alter efficacy of androgen-based therapies; consult prescriber |
| Immunosuppressants (e.g. ciclosporin, tacrolimus) |
Immunomodulatory activity may oppose immunosuppression | Contraindicated in post-transplant patients; consult specialist |
| This table reflects known or theoretically plausible interactions based on shilajit’s documented pharmacological mechanisms. It is not exhaustive. Consult a pharmacist or GP before combining shilajit with any prescription medication. | ||
Scientific Evidence on Shilajit Safety and Efficacy
The scientific literature on shilajit is growing but remains limited by study size. The majority of human clinical trials are small (n=20–60) and of short duration (4–12 weeks). Mechanistic studies using animal models and in vitro methods are more numerous. Extrapolating from mechanistic data to clinical recommendations requires caution.
Key Peer-Reviewed Findings on Safety
- A 90-day safety study in human volunteers found no clinically significant adverse effects at 500 mg/day of purified shilajit. Haematological and biochemical markers remained within normal ranges throughout. [PubMed: Bhavsar et al., 2012]
- A 2016 randomised controlled trial reported that 250 mg of purified shilajit twice daily for 90 days significantly increased total testosterone in healthy male volunteers aged 45–55, with no adverse biochemical markers. [PubMed: Pandit et al., 2016]
- A 2019 study found that shilajit supplementation improved mitochondrial function markers in skeletal muscle — a mechanism that may explain reported fatigue-reduction effects. [PubMed: Bhardwaj et al., 2019]
- A 2025 elemental analysis study of commercial shilajit products identified thallium levels above any established safety benchmark in several processed supplements. This finding has not yet been replicated but is consistent with known geological contamination patterns.
Where Evidence Is Insufficient
- Long-term safety data beyond 12 weeks is absent from the clinical literature.
- No large randomised controlled trials exist for any specific health indication.
- No human pharmacokinetic studies exist characterising absorption, distribution, and elimination of shilajit’s key components in clinical settings.
- No paediatric safety data exists for any shilajit form or preparation.
The absence of long-term safety data does not mean long-term use is unsafe. It means the question has not been adequately studied. UK consumers should interpret positive short-term safety data conservatively and apply additional caution if using shilajit over extended periods.
Safe Dosage and Usage Guidelines for Shilajit in the UK
No UK regulatory authority has established an official Recommended Daily Intake (RDI) for shilajit. Dosage guidance is derived from clinical trial protocols and traditional usage parameters. The following ranges reflect the consensus across published clinical studies.
| Parameter | Recommended Range | Source / Basis | Caution Notes |
|---|---|---|---|
| Standard daily dose (purified resin) | 300–500 mg/day | Multiple clinical trials; Bhavsar et al., 2012; Pandit et al., 2016 | Do not exceed without medical supervision |
| Minimum effective dose | 200 mg/day | Traditional Ayurvedic dosing; no human RCT below 250 mg | Evidence is limited at this level |
| Upper observed safe limit | 500 mg/day (short-term studies) | 90-day safety trial, Bhavsar et al., 2012 | No long-term safety data beyond 12 weeks |
| Timing | With warm water, morning; empty stomach or with food | Clinical trial protocols; traditional usage | Avoid taking late at night due to potential stimulatory effect |
| Cycling recommendation | 8 weeks on, 2 weeks off | Traditional Ayurvedic protocol; no RCT validation | Tier 3 — not clinically validated; precautionary practice |
| Dosage applies to purified shilajit resin only. Capsule and powder formulations may contain lower active concentrations — verify COA for actual fulvic acid content per serving. | |||
For correct preparation and usage of shilajit resin specifically, see the detailed how to use shilajit UK guide.
Lab Testing Standards: What a Valid Certificate of Analysis Must Include
A Certificate of Analysis (COA) is a laboratory document confirming that a specific batch of a product meets defined quality parameters. Not all COAs are equivalent. The following framework defines what a valid, trustworthy COA must contain for shilajit sold in the UK.
ISO 17025 Accreditation: The Minimum Standard
ISO/IEC 17025 is the international standard for testing and calibration laboratories. Only ISO 17025-accredited laboratories produce results that are internationally recognised, comparable, and legally defensible. [UKAS: ISO 17025 Accreditation]
UK consumers should verify that any COA cited by a shilajit brand is issued by a laboratory with ISO 17025 accreditation. Recognised laboratories operating in this space include SGS, Eurofins Scientific, and Intertek. Accreditation status can be verified directly on the UKAS (UK Accreditation Service) register.
| COA Component | Required? | Why It Matters | Red Flag If Absent |
|---|---|---|---|
| Laboratory name and ISO 17025 accreditation number | ✔ Mandatory | Confirms results are from an accredited, traceable laboratory | Results are unverifiable without accreditation reference |
| Batch number or lot number | ✔ Mandatory | Confirms COA applies to specific batch, not a generic product test | A COA without a batch number may be fabricated or reused |
| Test date | ✔ Mandatory | Confirms testing is recent and not stale documentation | Undated COAs cannot be trusted as current |
| Fulvic acid percentage (gravimetric or spectrophotometric) | ✔ Mandatory | Primary bioactive quality indicator; must be verified, not claimed | Without verified %, bioavailability claims are unsubstantiated |
| Heavy metal panel: Pb, As, Hg, Cd (numerical values) | ✔ Mandatory | Core safety data; absence of numbers = absence of safety verification | High risk — potential contaminant exposure cannot be assessed |
| Microbial safety panel (Total Plate Count, E. coli, Salmonella) | ✔ Mandatory | Confirms product is free of harmful microbial contamination | Absent microbial testing is a food safety violation risk |
| Moisture content | Recommended | Affects shelf stability and active concentration per gram | Absence is not disqualifying but reduces quality confidence |
| Standard: ISO/IEC 17025:2017. UK accreditation verification: ukas.com. Applicable pharmacopoeial heavy metal limits: USP <232> and ICH Q3D. | |||
Nature Elixirs publishes all required COA components — including batch-specific heavy metal numerical values and microbial safety results — on its certificates page. This is the transparency standard all UK shilajit brands should be held to.
Buyer Safety Decision Framework: How to Evaluate Any UK Shilajit Product
This section provides a sequential verification protocol for any UK consumer evaluating a shilajit product for safety. Each step must be completed in order. A failure at any step is grounds to reject or further scrutinise the product.
- Locate the Certificate of Analysis The COA must be published on the brand’s website or directly available on request. It must reference a specific batch number. A generic “tested for quality” statement is not a COA.
- Verify the testing laboratory Confirm ISO 17025 accreditation via the UKAS register (ukas.com) or equivalent national accreditation body. Accepted labs: SGS, Eurofins, Intertek, and other UKAS-registered facilities.
- Check heavy metal numerical values Lead must be below 10 µg/day (WHO) or 5 µg/day (USP). Arsenic below 10 µg/day. Mercury below 2 µg/day. Cadmium below 4.1 µg/day (USP). Values stated as “pass” without numbers are insufficient.
- Confirm fulvic acid concentration A minimum of 60% fulvic acid is required for therapeutic relevance. Premium products from verified high-altitude Himalayan sources should show 70–80%. Anything below 40% is sub-standard.
- Cross-reference source altitude and purity claims Sourcing above 16,000 feet reduces industrial contamination risk. Verify this is stated in product documentation, not only in marketing copy. For detailed fake-product detection, see the real vs fake shilajit identification guide.
Product Form Safety Comparison
Product form affects both bioavailability and contamination risk. The resin vs capsules vs powder comparison provides a complete analysis, but the safety-relevant summary is as follows:
| Form | Processing Level | Adulteration Risk | COA Verifiability | Safety Recommendation |
|---|---|---|---|---|
| Pure Resin | Minimal — water extraction only | Low (if sourced directly) | High — batch-specific testing straightforward | Best Choice — with published COA |
| Standardised Extract Capsules | Moderate — extraction + standardisation | Medium — fillers, flow agents possible | Medium — depends on brand transparency | Acceptable — if COA includes carrier agents |
| Powder | High — spray-drying, carrier dilution | High — most adulterated form | Low — active content per gram hardest to verify | Highest Risk — avoid without full COA |
| Gummies | Maximum — trace mineral content negligible | Very High — primary ingredient is typically sugar | Negligible — shilajit content untestable at trace levels | Avoid — no therapeutic value; safety unverifiable |
| Form assessment based on processing steps, published adulteration research, and COA practicability. Safety rating assumes worst-case scenario for each form without COA verification. | ||||
Shilajit Safety Red Flags: Market-Specific Warning Signals (UK 2026)
The following product signals indicate elevated safety or quality risk. Each is based on documented market patterns or scientific literature, not opinion.
- No COA published on brand website — claim of testing without documentation is unverifiable
- COA without batch number — document cannot be matched to your specific product lot
- Heavy metals listed as “compliant” or “pass” without numerical values
- Fulvic acid content not quantified by third-party lab — only stated on packaging
- Source altitude unspecified or generic (“Himalayan” without elevation data)
- Price significantly below market average (under £15 for 30g) — cannot fund genuine third-party testing at that margin
- Product stretches into long threads when pulled — indicates added sugar or binding agents
- Sweet smell or chemical smell — authentic shilajit has a strong, natural mineral-earthy odour only
- Lab reports hosted on third-party review sites rather than brand’s own domain — chain of custody unverifiable
Shilajit Is Safe When Verified. Risky When It Isn’t.
Pure, purified, and independently certified shilajit from a verified high-altitude Himalayan source presents a low safety risk for healthy adults at 300–500 mg/day. The safety profile of the product category as a whole is irreparably heterogeneous because the UK market contains both rigorously tested products and unverified products with documented heavy metal contamination risks.
Nature Elixirs Pure Himalayan Shilajit Resin is sourced at 18,000+ feet, contains approximately 75% fulvic acid by verified COA, and publishes full batch-specific heavy metal panels from accredited laboratories publicly. It meets all five criteria of the buyer verification framework above.
- 75% verified fulvic acid — confirmed by ISO 17025-accredited lab
- Full heavy metal panel published — Pb, As, Hg, Cd numerical values available
- 18,000+ ft Himalayan source — minimises industrial contamination exposure
- Non-GMO, no additives, no artificial agents — 100% pure resin
- All certificates and lab reports publicly accessible before purchase
Frequently Asked Questions: Shilajit Safety UK
A 90-day clinical safety study found no adverse biochemical changes in healthy adults taking 500 mg/day of purified shilajit. [PubMed: Bhavsar et al., 2012] Daily use is considered acceptable within this evidence window. Long-term data beyond 12 weeks does not exist in the peer-reviewed literature, so caution is appropriate for continuous use beyond 3 months without a break.
No peer-reviewed study has established shilajit as hepatotoxic at clinical doses in humans. However, unverified products containing elevated heavy metals (particularly arsenic and cadmium) carry hepatotoxic risk at repeated exposure. Individuals with pre-existing liver conditions should avoid shilajit as a precautionary measure. Always consult a hepatologist or GP before use if liver function is a concern.
Clinical trial data on shilajit’s safety in women is sparse. The majority of published human trials have enrolled male volunteers. Women who are not pregnant or breastfeeding and who have no iron-overload conditions may use verified shilajit at standard doses, but should note that hormonal effects documented in male studies have not been studied in female populations. Pregnant and breastfeeding women should not take shilajit.
Documented or theoretically plausible interactions exist with antihypertensives, anticoagulants, iron supplements, diabetes medications, and immunosuppressants. The drug interaction database for shilajit is incomplete because no systematic pharmacokinetic interaction studies exist. Consult a pharmacist or GP before combining shilajit with any prescription medication.
Require a batch-specific Certificate of Analysis (COA) from an ISO 17025-accredited laboratory. The COA must include numerical heavy metal values (not just “pass”), a verified fulvic acid percentage, and a microbial safety panel. Verify the laboratory’s accreditation status on the UKAS register at ukas.com. Review the full process at Nature Elixirs’ lab reports page for a reference standard.
No supplement carries zero risk for all individuals. However, purified shilajit from a high-altitude Himalayan source, independently tested by an accredited laboratory with published results showing heavy metals below WHO/USP thresholds, presents a low-risk profile for healthy adults. Risk is minimised through source altitude, purification quality, and third-party verification — not through marketing claims.
For a complete picture of shilajit quality and verification in the UK:
This article is provided for informational purposes only and does not constitute medical advice. The content is not intended to diagnose, treat, cure, or prevent any health condition. Information on drug interactions, contraindications, and side effects is indicative, not exhaustive. Always consult a qualified healthcare professional (GP, pharmacist, or specialist) before starting any new supplement, particularly if you have a medical condition or take prescription medication. Nature Elixirs is not liable for individual supplement decisions made based on this content.
